Thompson G R
Hammersmith Hospital, London.
Br J Hosp Med. 1989 Oct;42(4):268-70, 272-4.
Hyperlipidaemia is a major cause of coronary heart disease (CHD) and is especially prevalent in Britain. Prior to lipid-lowering therapy it is necessary to define the type of lipoprotein abnormality present and whether it is primary or secondary. Diet forms the initial treatment but additional drug therapy may be necessary in patients with established CHD or considered to be at high risk of developing CHD or rarely, in the case of severe hypertriglyceridaemia, acute pancreatitis.
高脂血症是冠心病（CHD）的主要病因，在英国尤为普遍。在进行降脂治疗之前，有必要确定存在的脂蛋白异常类型以及它是原发性还是继发性的。饮食是初始治疗方法，但对于已确诊冠心病或被认为有患冠心病高风险的患者，可能需要额外的药物治疗；在极少数情况下，对于严重高甘油三酯血症导致急性胰腺炎的患者，也需要药物治疗。
